Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

Galecto, Inc. Common Stock (GLTO)

Pharmaceutical Preparations

https://www.galecto.com

Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of fibrosis and impact a broad range of fibrotic and related diseases, including cancer. Its initial focus is on the development of small-molecule inhibitors of galectin-3 and lysyl oxidase-like 2, or LOXL2. Its product candidate GB0139 is for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, a life-threatening progressive fibrotic disease of the lung. Its product GB1211, a selective oral galectin-3 inhibitor for the treatment of fibrosis-related to non-alcoholic steatohepatitis, or NASH, and GB2064, a selective oral inhibitor of LOXL2 that it initially plans to develop for the treatment of myelofibrosis.

75 STATE STREET, SUITE 100
BOSTON, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

10/29/2020

Market Cap

15,740,942

Shares Outstanding

27,110,000

Weighted SO

27,112,697

Total Employees

N/A

Upcoming Earnings

07/29/2024

Similar Tickers

TERN --.--%

DAWN --.--%

ABOS --.--%

AMLX --.--%

MLTX --.--%

MOLN --.--%

CYT --.--%

CNTA --.--%

EWTX --.--%

Beta

1.1790

Last Div

0.0000

Range

0.46-0.94

Chg

0.0300

Avg Vol

155459

Mkt Cap

15740942

Exch

NASDAQ

Country

US

Phone

457 070 5210

DCF Diff

-0.2156

DCF

0.7984

Div Yield

0.0000

P/S

13.0956

EV Multiple

0.3781

P/FV

0.6670

Div Yield %

0.0000

P/E

-0.6188

PEG

-0.0151

Payout

0.0000

Current Ratio

6.7857

Quick Ratio

6.7857

Cash Ratio

6.1639

DSO

522.5998

DIO

0.0000

Op Cycle

522.5998

DPO

342.7497

CCC

179.8502

Gross Margin

0.3586

Op Margin

-20.7022

Pretax Margin

-21.1181

Net Margin

-21.1531

Eff Tax Rate

-0.0423

ROA

-0.9315

ROE

-0.8373

ROCE

-1.0549

NI/EBT

1.0017

EBT/EBIT

1.0201

EBIT/Rev

-20.7022

Debt Ratio

0.0028

D/E

0.0033

LT Debt/Cap

0.0000

Total Debt/Cap

0.0033

Int Coverage

-49.9679

CF/Debt

-389.1428

Equity Multi

1.1572

Rec Turnover

0.6984

Pay Turnover

1.0649

Inv Turnover

0.0000

FA Turnover

8.4056

Asset Turnover

0.0440

OCF/Share

-1.1050

FCF/Share

-1.1050

Cash/Share

0.8431

OCF/Sales

-24.9285

FCF/OCF

1.0000

CF Coverage

-389.1428

ST Coverage

-389.1428

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

0.6670

P/B

0.6670

P/S

13.0956

P/E

-0.6188

P/FCF

-0.5253

P/OCF

-0.5250

P/CF

-0.5250

PEG

-0.0151

P/S

13.0956

EV Multiple

0.3781

P/FV

0.6670

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation